Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metabolic Alterations in a Drosophila Model of Parkinson’s Disease Based on DJ-1 Deficiency
Cristina Solana‐Manrique, F. Sanz, Isabel Torregrosa, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 331-331
Open Access | Times Cited: 21

Showing 21 citing articles:

Antioxidant and Neuroprotective Effects of Carnosine: Therapeutic Implications in Neurodegenerative Diseases
Cristina Solana‐Manrique, F. Sanz, Guillermo Martínez‐Carrión, et al.
Antioxidants (2022) Vol. 11, Iss. 5, pp. 848-848
Open Access | Times Cited: 52
Dopaminergic neuron metabolism: relevance for understanding Parkinson’s disease
Xóchitl Flores-Ponce, Iván Velasco
Metabolomics (2024) Vol. 20, Iss. 6
Open Access | Times Cited: 7
Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with In Vitro and In Vivo Activity in Neurodegenerative Diseases
Mireia Toledano‐Pinedo, Alicia Porro-Pérez, Linda Schäker‐Hübner, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 5
Using Single-Cell RNA sequencing with Drosophila, Zebrafish, and mouse models for studying Alzheimer’s and Parkinson’s disease
Faye T.C. Lau, Rebecca Binacchi, S. Brugnara, et al.
Neuroscience (2025)
Open Access
Exploring Diagnostic Markers and Therapeutic Targets in Parkinson’s Disease: A Comprehensive 1H-NMR Metabolomic Analysis – Systematic Review
Andrzej Wasilewski, Eliza Wasilewska, Agata Serrafi
Archivum Immunologiae et Therapiae Experimentalis (2025) Vol. 73, Iss. 1
Closed Access
Resveratrol and ceftriaxone encapsulated in hybrid nanoparticles to prevent dopaminergic neurons from degeneration for Parkinson's disease treatment
Jen‐Tsung Yang, Yung‐Chih Kuo, K.E. Lee, et al.
Biomaterials Advances (2024) Vol. 166, pp. 214065-214065
Closed Access | Times Cited: 2
DJ-1 promotes energy balance by regulating both mitochondrial and autophagic homeostasis
Federica De Lazzari, Francesco Agostini, Nicoletta Plotegher, et al.
Neurobiology of Disease (2022) Vol. 176, pp. 105941-105941
Open Access | Times Cited: 10
A new metabolic model ofDrosophila melanogasterand the integrative analysis of Parkinson’s disease
Müberra Fatma Cesur, Arianna Basile, Kiran Raosaheb Patil, et al.
Life Science Alliance (2023) Vol. 6, Iss. 8, pp. e202201695-e202201695
Open Access | Times Cited: 5
Molecular and Physiological Determinants of Amyotrophic Lateral Sclerosis: What the DJ-1 Protein Teaches Us
Federica Sandrelli, Marco Bisaglia
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 8, pp. 7674-7674
Open Access | Times Cited: 5
Extensive multiregional urea elevations in a case-control study of vascular dementia point toward a novel shared mechanism of disease amongst the age-related dementias
Sasha A. Philbert, Jingshu Xu, Melissa Scholefield, et al.
Frontiers in Molecular Neuroscience (2023) Vol. 16
Open Access | Times Cited: 5
Exploring the link between Parkinson's disease and type 2 diabetes mellitus in Drosophila
F. Sanz, Cristina Solana‐Manrique, Joaquín Lilao‐Garzón, et al.
The FASEB Journal (2022) Vol. 36, Iss. 8
Open Access | Times Cited: 7
Progress in Parkinson's disease animal models of genetic defects: Characteristics and application
Chutian Zhang, Shiya Chen, Xiyu Li, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 155, pp. 113768-113768
Open Access | Times Cited: 7
Evaluation of type 1 diabetes mellitus as a risk factor of Parkinson's disease in a Drosophila model
F. Sanz, Guillermo Martínez‐Carrión, Cristina Solana‐Manrique, et al.
Journal of Experimental Zoology Part A Ecological and Integrative Physiology (2023) Vol. 339, Iss. 8, pp. 697-705
Open Access | Times Cited: 4
Disease-Modifying Effects of Vincamine Supplementation in Drosophila and Human Cell Models of Parkinson’s Disease Based on DJ-1 Deficiency
F. Sanz, Cristina Solana‐Manrique, Nuria Paricio
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 12, pp. 2294-2301
Open Access | Times Cited: 2
Metabolomics in neurodegenerative disorders—Parkinson’s disease
Ananya Gupta, Iipsha Bhaduri, Anubhuti Dixit
Comprehensive analytical chemistry (2024), pp. 161-181
Closed Access
Flight to insight: maximizing the potential of Drosophila models of C9orf72-FTD
Nicole A. d’Almeida, Marla Tipping
Frontiers in Molecular Neuroscience (2024) Vol. 17
Open Access
Study of Optimal Stimulation Parameters in Drosophila Based on a Baseline Control Model
Yichun Wang
Learning and analytics in intelligent systems (2024), pp. 682-691
Closed Access
Mitochondrial Dysfunction as a Potential Mechanism Mediating Cardiac Comorbidities in Parkinson’s Disease
Alberto Torres, Jieun Lee, Andrea Caporali, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 10973-10973
Open Access
Disease-modifying effects of Vincamine supplementation inDrosophilaand human cell models of Parkinson’s disease
F. Sanz, Cristina Solana‐Manrique, Nuria Paricio
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Exploring the link between Parkinson’s disease and Diabetes Mellitus in Drosophila
F. Sanz, Cristina Solana‐Manrique, Joaquín Lilao‐Garzón, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Closed Access
Extensive multiregional urea elevations in vascular dementia point towards a novel shared mechanism of disease amongst the age-related dementias
Sasha A. Philbert, Jingshu Xu, Melissa Scholefield, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top